Navigation Links
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery
Date:11/19/2012

NEW YORK, Nov. 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery  
http://www.reportlinker.com/p01042201/United-States-Oncology-Drug-Delivery-Preferences-and-Opportunities-in-Cancer-Drug-Delivery .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology Research Objectives

•Understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients in key treatment settings such as home, office, or infusion center.
•Identify physician prescribing trends relative to drug delivery considerations.
•Understanding the role of reimbursement in physician's choice of drug delivery.
•Identify physicians' perception of different drug delivery approaches, as well as key drivers for adoption/non-adoption, compliance, and choice of delivery devices.
•Identify drug delivery trends within the oncology area.
•Determine product attributes relative to delivery that are considered to be important by physicians and patients.
•Identify prospective patient preferences and willingness to try new technologies as well as determine key drivers of adoption/non-adoption.

Industry Background

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In oncology, developers are interested in understanding the opportunities and parameters for delivery of drugs in outpatient settings, particularly in the home. This is important for biotechnology products used in this area as companies seek to design new products and evaluate new opportunities for targeted therapies and other cancer treatments.

Scope: Drug Delivery Categories

The eleven drug delivery categories evaluated in this research are:
•Intravenous injection
•Subcutaneous (SC) injection
•Intramuscular (IM) injection
•Intravenous infusion
•Implantable infusion pump
•External infusion pump
•Transdermal patch
•Topical gel or cream
•Implant
•Oral
•Rectal

Executive Summary

•Across all cancer types, oral is currently the dominant ( percent) mode of drug delivery. Meanwhile, the availability and prescription of effective implantable infusion pump as an oncology drug delivery mode has the potential for higher patient acceptance compared to external infusion pump. However, a significant proportion ( percent) of patients who are unwilling to use external infusion pumps will still comply if the method is prescribed by a doctor.
•While cancer patients are least familiar with topical gel or cream for oncology treatment, percent of respondents reported that they would be willing to use this method for future oncology treatments, implying a potential for high growth rate.
•Although external infusion pump remains in the top three most utilized oncology drug delivery methods, utilization rates within cancer types has decreased.

•For Lung Cancer, oral is currently the dominant ( percent) delivery method. Since topical gel or cream has a high utilization rate ( percent), high satisfaction rate ( percent), and a strong rate ( percent) of willingness to use, it appears that topical gel or cream could be positioned to grow as an oncology drug delivery method of choice for lung cancer patients.
•Although it is not a top-three treatment option, rectal drug delivery has the overall highest utilization rate when comparing mean scores ( ) among all cancer types, implying a potential for market share growth.
•Lung cancer patients are least familiar with external infusion pump ( percent) for oncology treatment, and only half of respondents report that they are willing to use external infusion pumps for future oncology treatments.

•For Colorectal Cancer, external infusion pump delivery is currently dominant. Although the most-used oncology drug delivery methods among colorectal cancer patients are invasive, these patients prefer non-invasive treatment options the most: transdermal patch ( percent), topical gel/cream (86 percent), and oral ( percent).
•The potential to increase the usage of transdermal patches is high, considering the high proportion of willing users and that there is high satisfaction with this drug delivery method.
•External infusion pump is used more often by colorectal cancer patients than any of the other surveyed cancers.

Table of Contents

Section
Slide Numbers
Research Objectives and Methods
Executive Summary and Implications

Profile of Respondents

Awareness and Utilization of Oncology Drug Delivery Methods

Perceptions, Attitudes and Willingness to Use Drug Delivery Methods

Preference for and Satisfaction with Drug Delivery Methods

Preferred Setting for Treatment

Profile of Patients' Compliance

Criteria of Drug Delivery Selection

The Frost & Sullivan Story

To order this report:
Drug_Delivery_Technology Industry: United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery 

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
2. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
3. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
4. United Spinal To "Roll on Capitol Hill:" Voices Aim to Impact Federal Health Care Policy
5. United States ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
6. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
7. United Kingdom ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
8. United States Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
9. United States Market for Psoriatic Arthritis Pharmacotherapy
10. 2012 United States Medical Devices Outlook
11. Celladon Corporation Receives Patent from United States Patent and Trademark Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 Exactus ... company providing high-quality specialty pharmacy care for those ... today it has achieved full Specialty Pharmacy Accreditation ... organization dedicated to promoting health care quality through ... --> The URAC accreditation process ...
(Date:2/11/2016)... , Feb. 11, 2016 Scientists from ... method that opens the door to genetic analysis ... have been impossible to isolate with 100 percent ... specific tumor types in various stages of development, ... of these cells that are clinically relevant, and ...
(Date:2/11/2016)... , Feb. 11, 2016  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... will be made at the 38th annual John ... Care Symposium, which is being held February 14-18, 2016 ... covers the latest advancements in wound healing, burn care, ... Burn Association, Australian-New Zealand Burns Association, Academy of Physicians ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 11, 2016 , ... ... with their ongoing community involvement program, introduces a new charity campaign to raise ... donations are now being accepted at https://donate.rmhc.org/ . , Ronald McDonald House ...
(Date:2/11/2016)... ... 2016 , ... Be Well Medical Group (Be Well) is pleased ... at 108 South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is ... the convenience of their homes, offices or at the practices’ local office. It is ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling ... in health and wellness best practices in the past couple of decades, and ... is American Heart Month, which acts as an exceptional opportunity to revise food ...
(Date:2/10/2016)... ... February 10, 2016 , ... President ... Medicare Advantage organizations to deliver medical services via telehealth, estimated to generate more ... advocating for such language for many years. Although there is more to ...
(Date:2/10/2016)... ... ... LaserShip, a regional parcel carrier that services the eastern U.S., donated and delivered ... order to aid in the Flint water crisis. In 2014, LaserShip acquired Prestige Delivery ... only 15 miles away from Flint. , “We have deep roots in the local ...
Breaking Medicine News(10 mins):